These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16501222)

  • 21. Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.
    Wei G; Shea JE
    Biophys J; 2006 Sep; 91(5):1638-47. PubMed ID: 16766615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solvent Composition Effects on the Structural Properties of the Aβ42 Monomer from the 3D-RISM-KH Molecular Theory of Solvation.
    Blinov N; Wishart DS; Kovalenko A
    J Phys Chem B; 2019 Mar; 123(11):2491-2506. PubMed ID: 30811210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the structures of beta amyloid peptide (25-35) and substance P in trifluoroethanol/water solution.
    Lee S; Suh YH; Kim S; Kim Y
    J Biomol Struct Dyn; 1999 Oct; 17(2):381-91. PubMed ID: 10563586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the 21-30 fragment of amyloid beta-protein.
    Baumketner A; Bernstein SL; Wyttenbach T; Lazo ND; Teplow DB; Bowers MT; Shea JE
    Protein Sci; 2006 Jun; 15(6):1239-47. PubMed ID: 16731963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggregation rate of amyloid beta peptide is controlled by beta-content in monomeric state.
    Thu TTM; Co NT; Tu LA; Li MS
    J Chem Phys; 2019 Jun; 150(22):225101. PubMed ID: 31202253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid beta-protein: experiment and theory on the 21-30 fragment.
    Murray MM; Krone MG; Bernstein SL; Baumketner A; Condron MM; Lazo ND; Teplow DB; Wyttenbach T; Shea JE; Bowers MT
    J Phys Chem B; 2009 Apr; 113(17):6041-6. PubMed ID: 19341254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alpha-to-beta conformational transition of Alzheimer's Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding.
    Tomaselli S; Esposito V; Vangone P; van Nuland NA; Bonvin AM; Guerrini R; Tancredi T; Temussi PA; Picone D
    Chembiochem; 2006 Feb; 7(2):257-67. PubMed ID: 16444756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine Regulates β-Sheet Structure Formation in Amyloid-β
    Coskuner O; Uversky VN
    J Chem Inf Model; 2017 Jun; 57(6):1342-1358. PubMed ID: 28474890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers.
    Kłoniecki M; Jabłonowska A; Poznański J; Langridge J; Hughes C; Campuzano I; Giles K; Dadlez M
    J Mol Biol; 2011 Mar; 407(1):110-24. PubMed ID: 21237171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular dynamics simulations to investigate the structural stability and aggregation behavior of the GGVVIA oligomers derived from amyloid beta peptide.
    Chang LK; Zhao JH; Liu HL; Liu KT; Chen JT; Tsai WB; Ho Y
    J Biomol Struct Dyn; 2009 Jun; 26(6):731-40. PubMed ID: 19385701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of molecular dynamics simulation methods for amyloid β(1-42) monomers containing D-aspartic acid residues for predicting retention times in chromatography.
    Oda A; Kobayashi K; Takahashi O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(29):3337-43. PubMed ID: 21871847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and dynamics of parallel beta-sheets, hydrophobic core, and loops in Alzheimer's A beta fibrils.
    Buchete NV; Hummer G
    Biophys J; 2007 May; 92(9):3032-9. PubMed ID: 17293399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zn(2+) effect on structure and residual hydrophobicity of amyloid β-peptide monomers.
    Shi H; Kang B; Lee JY
    J Phys Chem B; 2014 Sep; 118(35):10355-61. PubMed ID: 25117080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monte Carlo study of the formation and conformational properties of dimers of Aβ42 variants.
    Mitternacht S; Staneva I; Härd T; Irbäck A
    J Mol Biol; 2011 Jul; 410(2):357-67. PubMed ID: 21616081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular dynamics simulation and computational two-dimensional infrared spectroscopic study of model amyloid β-peptide oligomers.
    Xu J; Zhang JZ; Xiang Y
    J Phys Chem A; 2013 Jul; 117(29):6373-9. PubMed ID: 23641734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structures and thermodynamics of Alzheimer's amyloid-beta Abeta(16-35) monomer and dimer by replica exchange molecular dynamics simulations: implication for full-length Abeta fibrillation.
    Chebaro Y; Mousseau N; Derreumaux P
    J Phys Chem B; 2009 May; 113(21):7668-75. PubMed ID: 19415895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of amyloid-β fibril elongation.
    Gurry T; Stultz CM
    Biochemistry; 2014 Nov; 53(44):6981-91. PubMed ID: 25330398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.